CTMX

CytomX Therapeutics (CTMX)

CytomX Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CTMX

<< 前へ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/11/22	20 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/11/18	20 : 25	TipRanks	CytomX Therapeutics (CTMX) Receives a Hold from H.C. Wainwright	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/11/18	01 : 17	Dow Jones News	CytomX Therapeutics Shares Rally on Regeneron Pact	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/11/17	23 : 25	TipRanks	Mizuho Securities Remains a Hold on CytomX Therapeutics (CTMX)	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/11/17	21 : 57	Dow Jones News	Regeneron, CytomX Set Cancer-Therapy Collaboration	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/11/17	21 : 00	PR Newswire (US)	Regeneron and CytomX Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/11/17	21 : 00	GlobeNewswire Inc.	CytomX and Regeneron Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/11/14	21 : 06	TipRanks	J.P. Morgan downgrades CytomX Therapeutics (CTMX) to a Sell	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/11/10	00 : 16	TipRanks	CytomX Therapeutics (CTMX) Receives a Buy from BMO Capital	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/11/09	20 : 35	TipRanks	CytomX Therapeutics (CTMX) Gets a Hold from H.C. Wainwright	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/11/09	17 : 35	TipRanks	Mizuho Securities Sticks to Their Hold Rating for CytomX Therapeutics (CTMX)	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/11/09	06 : 11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/11/09	06 : 10	GlobeNewswire Inc.	CytomX Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/11/09	06 : 04	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/11/08	06 : 15	GlobeNewswire Inc.	CytomX Therapeutics to Present Preclinical Data for Conditionally Activated Interferon Alpha-2b (CX-801) at the SITC 2022 Annual Meeting	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/11/03	05 : 15	GlobeNewswire Inc.	CytomX Therapeutics to Present at Upcoming November Investor Conferences	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/11/01	21 : 00	GlobeNewswire Inc.	CytomX Therapeutics to Report Third Quarter 2022 Financial Results on November 8, 2022	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/09/27	05 : 32	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/09/24	05 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/09/12	21 : 00	GlobeNewswire Inc.	CytomX Therapeutics Announces Phase 1 Data Update for anti-CTLA-4 Probody® Therapeutic BMS-986249	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/09/08	07 : 05	GlobeNewswire Inc.	CytomX Therapeutics Presents Overview of Conditionally-Activated Antibody-Drug Conjugate (ADC) Programs Including Next Generation EpCAM-Targeting CX-2051	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/09/06	08 : 15	TipRanks	CytomX Therapeutics (CTMX) Receives a Hold from Mizuho Securities	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/08/13	06 : 02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/08/13	06 : 02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/08/13	06 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/08/13	06 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/08/08	19 : 20	TipRanks	Wall Street Analysts Are Neutral on Top Healthcare Picks	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/08/05	21 : 33	TipRanks	Analysts Offer Insights on Healthcare Companies: Cigna (CI), Arrowhead Pharmaceuticals (ARWR) and CytomX Therapeutics (CTMX)	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/08/05	05 : 15	GlobeNewswire Inc.	CytomX Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update	NASDAQ:CTMX	CytomX Therapeutics Inc
2022/08/05	05 : 13	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTMX	CytomX Therapeutics Inc